Disclosure 0001193125-26-426878-1

SEC FORM 4

—

CRISPR Therapeutics AG (CRSP)

Acquisition (code M) of 100,000 shares; price not stated (see filing).

Reporting Person Kulkarni Samarth · Officer Title Chief Executive Officer · Transaction Code M

Traded Oct 16, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001193125-26-426878 · filed 2026-10-20 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "CRISPR Therapeutics AG (CRSP)." Disclosed 2026-10-20. https://desqlong.com/cards/0001193125-26-426878-1 (retrieved 2026-10-21).